ORCRY · Organo Corporation · Financials
Market Cap
$3.33B
Shares
229.91M
Volume · Oct 23
100
Avg daily vol (3 sessions)
700
You came from your AI assistant. Add Equibles to it and ask about this data directly, free.
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
177.65B
+8.8%
FY2026
Net Income
28.4B
+17.6%
FY2026
Gross Margin
36.64%
+2.8pp
FY2026
Operating Margin
21.19%
+2.1pp
FY2026
Operating Cash Flow
13.1B
-37.9%
FY2026
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | FY2026 | FY2025 | FY2024 | FY2023 | FY2022 |
|---|---|---|---|---|---|
| JPY | 177.65B | 163.27B | 150.36B | 132.43B | 112.07B |
| JPY | 112.57B | 108.09B | 106.51B | 97.45B | 83.56B |
| JPY | 65.08B | 55.18B | 43.84B | 34.98B | 28.51B |
| JPY | 37.65B | 31.12B | 22.54B | 15.21B | 10.85B |
| JPY | 38.31B | 32.36B | 23.63B | 16.04B | 12.7B |
| JPY | 9.91B | 8.17B | 6.3B | 4.27B | 3.47B |
| JPY | 28.4B | 24.15B | 17.31B | 11.73B | 9.21B |
Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Capital Returned to Shareholders
Cash spent on share repurchases and dividends per fiscal year, as reported on the cash-flow statement. Across FY2022–FY2026: 21.83B in dividends.
Debt Profile
No verified debt profile is available yet. This does not establish that the company has no debt or covenants.